Correlation Between Lixte Biotechnology and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Lixte Biotechnology and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lixte Biotechnology and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lixte Biotechnology Holdings and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Lixte Biotechnology and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lixte Biotechnology with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lixte Biotechnology and NLS Pharmaceutics.
Diversification Opportunities for Lixte Biotechnology and NLS Pharmaceutics
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Lixte and NLS is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Lixte Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lixte Biotechnology Holdings are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Lixte Biotechnology i.e., Lixte Biotechnology and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Lixte Biotechnology and NLS Pharmaceutics
Given the investment horizon of 90 days Lixte Biotechnology Holdings is expected to under-perform the NLS Pharmaceutics. But the stock apears to be less risky and, when comparing its historical volatility, Lixte Biotechnology Holdings is 1.57 times less risky than NLS Pharmaceutics. The stock trades about -0.08 of its potential returns per unit of risk. The NLS Pharmaceutics AG is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 303.00 in NLS Pharmaceutics AG on December 1, 2024 and sell it today you would lose (119.00) from holding NLS Pharmaceutics AG or give up 39.27% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Lixte Biotechnology Holdings vs. NLS Pharmaceutics AG
Performance |
Timeline |
Lixte Biotechnology |
NLS Pharmaceutics |
Lixte Biotechnology and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lixte Biotechnology and NLS Pharmaceutics
The main advantage of trading using opposite Lixte Biotechnology and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lixte Biotechnology position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd | Lixte Biotechnology vs. Indaptus Therapeutics |
NLS Pharmaceutics vs. Indaptus Therapeutics | NLS Pharmaceutics vs. Pasithea Therapeutics Corp | NLS Pharmaceutics vs. Quoin Pharmaceuticals Ltd | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |